{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:40:14Z","timestamp":1787506814406,"version":"build-2736575974"},"reference-count":11,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"vor","delay-in-days":3233,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2017,3,14]],"date-time":"2017-03-14T00:00:00Z","timestamp":1489449600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Non-ischemic cardiomyopathies (CMPs) comprise heart muscle disorders of different causes with high variability in disease phenotypes and clinical progression. The lack of national structures for the efficient recruitment, clinical and molecular classification, and follow-up of patients with non-ischemic CMPs limit the thorough analysis of disease mechanisms and the evaluation of novel diagnostic and therapeutic strategies. This paper describes a national, prospective, multicenter registry for patients with non-ischemic CMPs. The main objective of this registry is to create a central hub for clinical outcome studies, a joint resource for diagnostic and therapeutic trials, a common biomaterial bank, and a resource for detailed molecular analyses utilizing patients' biomaterials.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>A comprehensive characterization of the register population and patients' subgroups is planned. First analyses will include descriptive methods evaluating the distribution of outcome variables and possible risk factors followed by test statistics in a cross-sectional design. The aim of the current study is to recruit 2300 patients all over Germany. Eligible participants are patients with primary non-ischemic cardiomyopathies, including hereditary and inflammatory dilated CMP (DCM), left-ventricular noncompaction CMP (LVNC), hypertrophic CMP (HCM), arrhythmogenic right-ventricular CMP (ARVC), myocarditis, and amyloidosis. Of already recruited patients 70% are male and 30% female. With 56% of patients included, DCM is most common.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion\/Outcome<\/jats:title>\n                    <jats:p>The primary outcome is all-cause death. Key secondary endpoints are cardiovascular death, adequate ICD shock, survived sudden cardiac death, syncope, documented potentially life-threatening arrhythmia, cardiac transplantation, hospitalization due to worsening of heart failure (HF), and any non-elective cardiovascular hospitalization.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.12145","type":"journal-article","created":{"date-parts":[[2017,3,15]],"date-time":"2017-03-15T00:07:08Z","timestamp":1489536428000},"page":"209-215","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["TranslatiOnal Registry for CardiomyopatHies (TORCH) \u2013 Rationale and First Results"],"prefix":"10.1093","volume":"4","author":[{"given":"Claudia","family":"Seyler","sequence":"first","affiliation":[{"name":"Department of Cardiology, Medical University Hospital Heidelberg \u00a0","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Meder","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Medical University Hospital Heidelberg \u00a0","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Weis","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Medical University Hospital Heidelberg \u00a0","place":["Germany"]},{"name":"DZHK (German Centre for Cardiovascular Research), partner site Heidelberg\/Mannheim , Heidelberg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thea","family":"Schwaneberg","sequence":"additional","affiliation":[{"name":"Institute for Community Medicine , Greifswald ,","place":["Germany"]},{"name":"DZHK (German Centre for Cardiovascular Research), partner site Greifswald , Greifswald ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Weitmann","sequence":"additional","affiliation":[{"name":"Institute for Community Medicine , Greifswald ,","place":["Germany"]},{"name":"DZHK (German Centre for Cardiovascular Research), partner site Greifswald , Greifswald ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Hoffmann","sequence":"additional","affiliation":[{"name":"Institute for Community Medicine , Greifswald ,","place":["Germany"]},{"name":"DZHK (German Centre for Cardiovascular Research), partner site Greifswald , Greifswald ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo A.","family":"Katus","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Medical University Hospital Heidelberg \u00a0","place":["Germany"]},{"name":"DZHK (German Centre for Cardiovascular Research), partner site Heidelberg\/Mannheim , Heidelberg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"D\u00f6sch","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Medical University Hospital Heidelberg \u00a0","place":["Germany"]},{"name":"DZHK (German Centre for Cardiovascular Research), partner site Heidelberg\/Mannheim , Heidelberg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,3,14]]},"reference":[{"key":"2026012115133807200_ehf212145-bib-0001","first-page":"105","article-title":"Cardiomyopathies in the elderly","volume":"22","author":"Backes","year":"1992","journal-title":"Cardiovasc Clin"},{"key":"2026012115133807200_ehf212145-bib-0002","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1253\/circj.CJ-15-0174","article-title":"CHART-2 investigators. Prognostic Impact of Anemia in Patients With Chronic Heart Failure- With Special Reference to Clinical Background: Report From the CHART-2 Study","volume":"79","author":"Yamauchi","year":"2015","journal-title":"Circ J"},{"key":"2026012115133807200_ehf212145-bib-0003","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1007\/s00392-014-0743-x","article-title":"Characteristics, management modalities and outcome in chronic systolic heart failure patients treated in tertiary care centers: results from the EVIdence based TreAtment in Heart Failure (EVITA-HF) registry","volume":"103","author":"von Scheidt","year":"2014","journal-title":"Clin Res Cardiol"},{"key":"2026012115133807200_ehf212145-bib-0004","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.amjcard.2013.05.033","article-title":"Flynn KE; HF-ACTION Investigators. Hemoglobin, exercise training, and health status in patients with chronic heart failure (from the HF-ACTION randomized controlled trial)","volume":"112","author":"Pi\u00f1a","year":"2013","journal-title":"Am J Cardiol"},{"key":"2026012115133807200_ehf212145-bib-0005","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1056\/NEJMoa033088","article-title":"Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy","volume":"350","author":"Kadish","year":"2004","journal-title":"N Engl J Med"},{"key":"2026012115133807200_ehf212145-bib-0006","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1023\/B:CEPR.0000023162.45506.c4","article-title":"Kadish AH; DEFibrillators In Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE)","volume":"7","author":"Schaechter","year":"2003","journal-title":"Card Electrophysiol Rev"},{"key":"2026012115133807200_ehf212145-bib-0007","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.ahj.2004.10.031","article-title":"A prospective evaluation of the effect of simvastatin on heart rate variability in non-ischemic cardiomyopathy","volume":"150","author":"Gentlesk","year":"2005","journal-title":"Am Heart J"},{"key":"2026012115133807200_ehf212145-bib-0008","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s10557-008-6081-3","article-title":"Electrophysiological effects of carvedilol administration in patients with dilated cardiomyopathy","volume":"22","author":"Kanoupakis","year":"2008","journal-title":"Cardiovasc Drugs Ther"},{"key":"2026012115133807200_ehf212145-bib-0009","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0140-6736(01)06657-0","article-title":"Cardiomyopathies: from genetics to the prospect of treatment","volume":"358","author":"Franz","year":"2001","journal-title":"Lancet"},{"key":"2026012115133807200_ehf212145-bib-0010","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1146\/annurev.genom.6.080604.162132","article-title":"The genetic basis for cardiac remodeling","volume":"6","author":"Ahmad","year":"2005","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"2026012115133807200_ehf212145-bib-0011","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0735-1097(97)00434-8","article-title":"Frequency and phenotypes of familial dilated cardiomyopathy","volume":"31","author":"Grunig","year":"1998","journal-title":"J Am Coll Cardiol"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fehf2.12145","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/4\/3\/209\/66256910\/eschf_4_3_209.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/4\/3\/209\/66256910\/eschf_4_3_209.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T20:18:30Z","timestamp":1769026710000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/4\/3\/209\/8413095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,14]]},"references-count":11,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,3,14]]},"published-print":{"date-parts":[[2017,8,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.12145","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,8]]},"published":{"date-parts":[[2017,3,14]]},"assertion":[{"value":"2016-11-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-02-10","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-03-14","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}